Biography

Simona Sacco is professor of Neurology at the University of L’Aquila in Italy and Director of the local Clinical Neurology and Stroke Unit. Dr. Sacco is author of more than 300 publications in the field of stroke and headache.  She is the president elect of the European Stroke Organisation (ESO). She has extensive editorial activity and has the role of Editor-in-Chief of Cephalalgia and Cephalalgia reports; she is also assistant editor for Stroke, member of the editorial board of Neurology, European Stroke Journal and International Journal of Stroke. She has chaired the EHF Guideline on the use of monoclonal antibodies targeting the CGRP for migraine prevention, the EHF consensus on resistant and refractory migraine and the EHF consensus on triptan non-responders.

Disclosures

Employment: Full Professor of Neurology, University of L’Aquila; Head of Neurology Department ASL1 Abruzzo Avezzano-Sulmona-L’Aquila

Society Leadership/Board position: President elect European Stroke Organisation; Board of Directors Italian Society for the Study of Headache (SISC – Società Italiana per lo Studio delle Cefalee)

Personal fees: Fee as speaker or for participation to advisory board for Abbott, Allergan-Abbvie, AstraZeneca, Boheringer, Eli Lilly, Lundbeck, Novartis, NovoNordisk, Pfizer, Teva

Research support: Novartis and Uriach (all to institution)

Principal investigator: Local PI of ongoing clinical trials on atogepant, zavegepant, eptinezumab, asundexian, milvexian

Relationship with scientific journals: Editor-in-Chief Cephalalgia and Cephalagia Reports; Assistant Editor for Stroke; Editorial board for Neurology, European Stroke Journal, International Journal of Stroke, Neurological Sciences

Commercial interests: None